Papalocal
Loading…
Papalocal · People

Napoleone Ferrara

Italian molecular biologist
1956 – present · biologist · United States
20 facts · 1 confirmed
This profile was compiled from public sources, and may be incomplete or out of date. Are you Napoleone Ferrara? Sign in to claim your People Profile — edit it, add your input, or request changes/removal.

Napoleone Ferrara is an Italian molecular biologist. Born July 26, 1956, in Catania. Educated at University of Catania and University of California, San Francisco. Awards include Lasker-DeBakey Clinical Medical Research Award, Breakthrough Prize in Life Sciences and Canada Gairdner International Award.

Facts

20 facts · 1 confirmed by two sources · 6 cited · 13 from one source

Born
July 26, 1956 Confirmed
Born in
Catania One source
Citizen of
United States One source
Occupation
biologist One source
physician One source
molecular biologist One source
Field
endothelium One source

Where this comes from

Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.

What Wikidata says · copied November 19, 2026 · revision 2527150906
Described as
Italian molecular biologist
Born
July 26, 1956
Born in
Catania
Citizen of
United States
Occupation
biologist; physician; molecular biologist; researcher · 1 reference
Worked for
University of California, San Diego
Education
University of Catania; University of California, San Francisco
Member of
National Academy of Sciences; Accademia Nazionale dei Lincei (2025–) · 1 reference
Awards
Lasker-DeBakey Clinical Medical Research Award (2010) · 1 reference; Breakthrough Prize in Life Sciences (2013) · 1 reference; Canada Gairdner International Award (2014); Scientific Grand Prize of the Lefoulon-Delalande Fondation (2005) · 1 reference; Dr. Paul Janssen Award for Biomedical Research (2011) · 1 reference; Champalimaud Vision Award (2014); Clarivate Citation Laureates (2018) · 1 reference
Field
endothelium
Wikipedias with a page
12

Wikidata item Q1769254 (wikidata.org/wiki/Q1769254), public domain (CC0). Copied November 19, 2026.

What Wikipedia says · copied November 19, 2026 · revision 1372332465

Napoleone Ferrara (born 26 July 1956 in Catania, Sicily, Italy) is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development and FDA approval of the first clinically effective angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor. Bevacizumab, first approved for treatment of metastatic colorectal cancer in 2004, has become part of standard treatment for a variety of cancers. Ferrara's work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in patients with intraocular neovascular disorders such as neovascular AMD and retinal vein occlusion. Ranibizumab and other anti-VEGF agents represent the first effective therapy for such blinding disorders and rank among the most widely used drugs in older adults.

Born, in its opening lines
July 26, 1956

From the Wikipedia article “Napoleone Ferrara” (en.wikipedia.org/wiki/Napoleone_Ferrara), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied November 19, 2026; not changed.

Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.

Papalocal’s own record, started from Wikidata and Wikipedia.Report / request a correction